-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2024.
- Terns Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $24.9M, a 24.8% decline year-over-year.
- Terns Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $100M, a 4.88% increase year-over-year.
- Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $103M, a 65.3% increase from 2022.
- Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $62M, a 22% increase from 2021.
- Terns Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $50.9M, a 37.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)